PMID: 11921319Mar 29, 2002Paper

A general model of the impact of absenteeism on employers and employees

Health Economics
M PaulyM L Berger

Abstract

Most studies on the indirect costs of an illness and the cost effectiveness of a medical intervention or employer-sponsored wellness program assume that the value of reducing the number of days employees miss from work due to illness is the wage rate. This paper presents a general model to examine the magnitude and incidence of costs associated with absenteeism under alternative assumptions regarding the size of the firm, the production function, the nature of the firm's product, and the competitiveness of the labor market. We conclude that the cost of lost work time can be substantially higher than the wage when perfect substitutes are not available to replace absent workers and there is team production or a penalty associated with not meeting an output target. In the long run, workers are likely to bear much of the incidence of the costs associated with absenteeism, and therefore be the likely beneficiaries of any reduction in absenteeism.

References

Oct 9, 1996·JAMA : the Journal of the American Medical Association·L B RussellM C Weinstein
May 8, 1995·Journal of Health Economics·M A KoopmanschapL van Roijen
Apr 7, 1997·PharmacoEconomics·M Johannesson

❮ Previous
Next ❯

Citations

Mar 2, 2011·Clinical Rheumatology·Wei Zhang, Aslam H Anis
Feb 21, 2007·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Gisela KobeltBernard Uitdehaag
Apr 27, 2013·PharmacoEconomics·Marieke KrolFrans Rutten
Apr 13, 2004·AIDS·Sydney RosenJonathon L Simon
Oct 28, 2008·Public Health Nursing·Tara L DonovanElizabeth G VanDenKerkhof
Jul 9, 2011·Depression Research and Treatment·Kathryn RostAllen J Dietrich
Feb 8, 2005·PharmacoEconomics·Marc KoopmanschapHans Severens
Mar 8, 2005·PharmacoEconomics·Ernst BerndtGary H Lyman
Mar 3, 2005·CNS Drugs·Mark J Greener, Julian F Guest
Feb 10, 2006·Applied Health Economics and Health Policy·Sean NicholsonClaire E Sharda
Sep 16, 2009·American Journal of Health Promotion : AJHP·Chih-Wen PaiDee W Edington
Mar 19, 2014·PharmacoEconomics·Wei Zhang, Aslam H Anis
Jun 12, 2013·Tobacco Control·Anita LalTheo Vos
Oct 18, 2013·International Journal of Environmental Research and Public Health·Fiona CockerKristy Sanderson
Dec 19, 2014·BMC Health Services Research·Kathryn M RostStanley Xu
Dec 12, 2012·Best Practice & Research. Clinical Rheumatology·Wei ZhangAslam H Anis
Aug 23, 2011·Journal of Safety Research·Romain JallonNathalie de Marcellis-Warin
Dec 15, 2010·Social Science & Medicine·Wei ZhangAslam H Anis
Nov 8, 2015·Social Science & Medicine·Wei ZhangAslam Anis
Jul 7, 2007·Journal of Substance Abuse Treatment·Neil JordanScott Sangsland
Sep 28, 2015·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Clazien BouwmansLeona Hakkaart-van Roijen
Apr 3, 2003·The Milbank Quarterly·Ellen O'Brien
Jan 24, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Wei ZhangAslam H Anis
Aug 21, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·S KniesJ L Severens
Oct 27, 2005·Diabetes Care·Kaan TunceliJennifer Elston Lafata
Mar 25, 2016·Journal of Occupational Health·Abdur Razzaque SarkerJahangir A M Khan
Mar 11, 2003·Journal of Occupational and Environmental Medicine·Ronald C KesslerPhillip Wang
Dec 11, 2003·Journal of Occupational and Environmental Medicine·Marc L BergerClaire Sharda
Apr 27, 2018·Journal of Occupational and Environmental Hygiene·Amirabbas MofidiPaul A Demers
Jun 14, 2005·Journal of Occupational and Environmental Medicine·James J CollinsMarc L Berger
May 1, 2010·Journal of Occupational and Environmental Medicine·Amy L Neftzger, Shannon Walker
Aug 28, 2010·Journal of Occupational and Environmental Medicine·Kathleen LangJoseph Menzin
Oct 4, 2005·Health Economics·Sean NicholsonMarc L Berger

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.